Citations for
1ICOSLG
Development of a Novel Functional Monoclonal Antibody to Human CD275: Characterization and Biological Activity.
Hu X, Liu C, An J, Shen Y, Hu Y, Jiang J, Wu J, Zhang X.
Monoclon Antib Immunodiagn Immunother 35(1):18-24. doi: 10.1089/mab.2015.0059. 2016
2ICOSLG
T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction.
Liu D, Xu H, Shih C, Wan Z, Ma X, Ma W, Luo D, Qi H.
Nature 517(7533):214-8. doi: 10.1038/nature13803. 2015
3ICOSLG
Pattern recognition receptor signaling in human dendritic cells is enhanced by ICOS ligand and modulated by the Crohn's disease ICOSLG risk allele.
Hedl M, Lahiri A, Ning K, Cho JH, Abraham C.
Immunity 40(5):734-46. doi: 10.1016/j.immuni.2014.04.011. 2014
4ADAM17, ICOSLG
The role of metalloproteinase ADAM17 in regulating ICOS ligand-mediated humoral immune responses.
Marczynska J, Ozga A, Wlodarczyk A, Majchrzak-Gorecka M, Kulig P, Banas M, Michalczyk-Wetula D, Majewski P, Hutloff A, Schwarz J, Chalaris A, Scheller J, Rose-John S, Cichy J.
J Immunol 193(6):2753-63. doi: 10.4049/jimmunol.1302893. 2014
5ICOSLG
B7h (ICOS-L) maintains tolerance at the fetomaternal interface.
Riella LV, Dada S, Chabtini L, Smith B, Huang L, Dakle P, Mfarrej B, D'Addio F, Adams LT, Kochupurakkal N, Vergani A, Fiorina P, Mellor AL, Sharpe AH, Yagita H, Guleria I.
Am J Pathol 182(6):2204-13. doi: 10.1016/j.ajpath.2013.02.014. 2013
6ICOSLG, PRDM1, TNFRSF13B, TNFSF13B
Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival.
Ou X, Xu S, Lam KP.
Proc Natl Acad Sci U S A 109(38):15401-6. 2012
7ICOS, ICOSLG
ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells.
Faget J, Bendriss-Vermare N, Gobert M, Durand I, Olive D, Biota C, Bachelot T, Treilleux I, Goddard-Leon S, Lavergne E, Chabaud S, Blay JY, Caux C, Ménétrier-Caux C.
Cancer Res 72(23):6130-41. doi: 10.1158/0008-5472.CAN-12-2409. 2012
8ICOS, ICOSLG
Involvement of inducible costimulator ligand (ICOSL) expression in thyroid tissue in hyperthyroidism of Graves' disease patients.
Wang F, Yan T, Chen L, Chen X, Liu T, Shen S, Li T, Gao L, Wang T, Sun J, Liu C, Wu H, Zhang X, Chen L.
J Clin Immunol 32(6):1253-61. doi: 10.1007/s10875-012-9711-2. 2012
9CTLA4, ICOSLG
B7-h2 is a costimulatory ligand for CD28 in human.
Yao S, Zhu Y, Zhu G, Augustine M, Zheng L, Goode DJ, Broadwater M, Ruff W, Flies S, Xu H, Flies D, Luo L, Wang S, Chen L.
Immunity 34(5):729-40. doi: 10.1016/j.immuni.2011.03.014. 2011
10ICOSLG
Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
Her M, Kim D, Oh M, Jeong H, Choi I.
Lupus 18(6):501-7. doi: 10.1177/0961203308099176. 2009
11ICOS, ICOSLG
Down-regulation of ICOS ligand by interaction with ICOS functions as a regulatory mechanism for immune responses.
Watanabe M, Takagi Y, Kotani M, Hara Y, Inamine A, Hayashi K, Ogawa S, Takeda K, Tanabe K, Abe R.
J Immunol 180(8):5222-34. 2008
12ICOS, ICOSLG
Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies.
Hu W, Janke A, Ortler S, Hartung HP, Leder C, Kieseier BC, Wiendl H.
Neurology 68(4):277-82. 2007
13ICOSLG
Renal tubular epithelial cells modulate T-cell responses via ICOS-L and B7-H1.
de Haij S, Woltman AM, Trouw LA, Bakker AC, Kamerling SW, van der Kooij SW, Chen L, Kroczek RA, Daha MR, van Kooten C.
Kidney Int 68(5):2091-102. 2005
14ICOSLG
Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia.
Tamura H, Dan K, Tamada K, Nakamura K, Shioi Y, Hyodo H, Wang SD, Dong H, Chen L, Ogata K.
Clin Cancer Res 11(16):5708-17. 2005
15ICOSLG
Expression of the costimulatory molecule B7-H2 (inducible costimulator ligand) by human airway epithelial cells.
Kurosawa S, Myers AC, Chen L, Wang S, Ni J, Plitt JR, Heller NM, Bochner BS, Schleimer RP.
Am J Respir Cell Mol Biol 28(5):563-73. 2003
16ICOSLG
Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS.
Wang S, Zhu G, Chapoval AI, Dong H, Tamada K, Ni J, Chen L.
Blood 96(8):2808-13. 2000
17ICOSLG
Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor.
Ling V, Wu PW, Finnerty HF, Bean KM, Spaulding V, Fouser LA, Leonard JP, Hunter SE, Zollner R, Thomas JL, Miyashiro JS, Jacobs KA, Collins M.
J Immunol 164(4):1653-7. 2000
18ICOSLG
Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS.
Yoshinaga SK, Zhang M, Pistillo J, Horan T, Khare SD, Miner K, Sonnenberg M, Boone T, Brankow D, Dai T, Delaney J, Han H, Hui A, Kohno T, Manoukian R, Whoriskey JS, Coccia MA.
Int Immunol 12(10):1439-47. 2000
19AATK, ACIN1, ACOT11, ACSBG1, ADAMTS4, ADGRV1, AKAP11, ANKLE2, ARHGAP26, ARHGEF2, ASTN2, ATP2C2, ATP9A, BICD2, BZRAP1, C12orf51, CAND2, CEP135, CLASP1, CLASP2, CLUAP1, CLUH, CNOT3, COBL, CPNE3, CRTC1, CRY2, CSTF2T, CUL3, CUL4B, DAAM1, DAGLA, DEPDC5, DNAJC13, DOCK10, DZIP3, FBXW11, FKBP15, G3BP2, HEPH, HIP1R, HIPK1, ICOSLG, KIAA0649, KIAA0652, KIF13B, KIF1C, KIF21A, L3MBTL1, LDB3, MAGI2, MAP4K4, MFAP3L, MGEA5, MRC2, MTMR4, N4BP1, NPHP4, OBSL1, PAN2, PHACTR2, PHF2, PHLDB1, PLXND1, PPFIA3, PTCD1, RAB11FIP3, RBM19, RICH2, RNF40, RNF8, ROCK2, RRP12, SAPS2, SETX, SIN3B, SLC24A1, SMCHD1, SNAP91, SOCS5, SS18L1, SWAP70, TBC1D9B, TELO2, TNRC15, TSC22D2, UBE4B, UHRF1BP1L, ULK2, ZBED4, ZC3H11A, ZNF623
Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.
Ishikawa K, Nagase T, Suyama M, Miyajima N, Tanaka A, Kotani H, Nomura N,Ohara O.
DNA Res 5(3):169-76. 1998